US 11603412
Antibodies against CDCP1 for the treatment and detection of cancer
granted A61KA61K47/68031A61K47/6849
Quick answer
US patent 11603412 (Antibodies against CDCP1 for the treatment and detection of cancer) held by The Regents of the University of California expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K47/68031, A61K47/6849, A61P, A61P35/00